Abstract:Allergic rhinitis (AR) is one of the most common chronic inflammatory diseases and its main feature is nasal mucositis. It has been recently revealed that lidocaine demonstrates optimal effects in the treatment of various diseases. However, a limited number of studies have examined the association between lidocaine and AR. In the present study, the AR mouse model was established to explore the effects of lidocaine in AR and to further analyze its molecular mechanism. Subsequently, different concentrations of lidocaine were provided to the animals by intranasal administration and a series of indices were assessed. The data indicated that the frequencies of mouse sneezing and nose rubbing were suppressed following an increase in lidocaine concentration. Subsequently, the number of inflammatory cells was measured. Wright's-Giemsa staining results indicated that lidocaine significantly decreased the numbers of leukocytes, eosinophils, neutrophils and lymphocytes in the nasal lavage fluid (NLF) of AR mice. In addition, the expression levels of ovalbumin (OVA)-specific immunoglobulin E (IgE), leukotriene C4 (LTC4) and certain inflammatory factors were assessed by ELISA. Lidocaine reduced OVA-specific IgE and LTC4 expression in NLF and plasma derived from AR mice. It also decreased the expression levels of IL-4, IL-5, IL-13, IL-17 and TNF-α. Lidocaine caused upregulation of IFN-γ and IL-2 expression levels. Subsequently, western blot analysis indicated that lidocaine suppressed phosphorylated (p)-p38 and p-p65 expression levels in AR mice. Collectively, the results indicated that the NF-κB and p38 MAPK signaling pathways were involved in the lidocaine-mediated relief of AR in mice. In order to further verify the association between the NF-κB and p38 MAPK signaling pathways and AR in mice, the effects of the NF-κB inhibitor IMD-0354 and the p38 MAPK inhibitor SB 203580 were assessed on AR mice. The results indicated that these two compounds exhibited similar inhibitory effects on AR mice as those noted with the use of lidocaine. These findings suggested that lidocaine represented a novel therapeutic agent for AR.

Lidocaine Attenuates Proinflammatory Cytokine Production Induced By Extracellular Adenosine Triphosphate In Cultured Rat Microglia

Microrna 218 Modulates Pkc/Akt Pathway To Protect Lidocaine-Induced Neurotoxicity In Ganglia In Vitro

Attenuating Phosphorylation of P38 MAPK in the Activated Microglia: A New Mechanism for Intrathecal Lidocaine Reversing Tactile Allodynia Following Chronic Constriction Injury in Rats

Effect of intraperitoneal injection of Lidocaine on expression of NMDAR1 in spinal dorsal horn of a rat model of incisional pain

Lidocaine Potentiates SOCS3 to Attenuate Inflammation in Microglia and Suppress Neuropathic Pain

Lidocaine mediates the progression of cerebral ischemia/reperfusion injury in rats via inhibiting the activation of NF-κB p65 and p38 MAPK

Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization

Intravenous lidocaine alleviates postherpetic neuralgia in rats via regulation of neuroinflammation of microglia and astrocytes

Lidocaine hydrochloride increased apoptosis of SH-SY 5 Y cells through p 38 MARK mediated DNA methylation

The Protective Effect of Lidocaine on Lipopolysaccharide-Induced Acute Lung Injury in Rats Through NF-κB and P38 MAPK Signaling Pathway and Excessive Inflammatory Responses.

Effects of intrathecal lidocaine on hyperalgesia and allodynia following chronic constriction injury in rats.

Effects of lidocaine on the expression of intercellulor adhesion molecule-1 and NF- κB in hippocampus following cerebral ischemia-reperfusion in rats

Levo-corydalmine Attenuates Microglia Activation and Neuropathic Pain by Suppressing ASK1-p38 MAPK/NF-κB Signaling Pathways in Rat Spinal Cord.

Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain.

Lidocaine relieves murine allergic rhinitis by regulating the NF-κB and p38 MAPK pathways

Ribonucleic Acid Sequencing Reveals the Upregulation and Resolution of Inflammation and Extracellular Matrix Remodeling in Lidocaine-Treated Human Acute Monocytic Leukemia Cell Line THP-1

Effects of lidocaine on the expression of intercellulor adhesion molecule-1 in hippocampus following cerebral ischemia-reperfusion in rats

Analysis of the Long Non-Coding RNA and Mrna Expression Profiles Associated with Lidocaine-Induced Neurotoxicity in the Spinal Cord of a Rat Model.

Effect of TRPV1 Combined with Lidocaine on Cell State and Apoptosis of U87-MG Glioma Cell Lines.

Downregulation of MicroRNA-199a-5p Alleviated Lidocaine-Induced Sensory Dysfunction and Spinal Cord Myelin Lesions in a Rat Model.

[Effects of Intravenous Anesthetics on LPS-induced Production of Tumour Necrosis Factor-Alpha from Primary Cultures of Rat Glial Cells in Vitro].